Marinus Pharmaceuticals Stands Firm in Patent Dispute Over Key Epilepsy Treatment
RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a leader in developing treatments for rare genetic epilepsies and refractory seizure disorders, is currently embroiled in a legal battle to protect …
Marinus Pharmaceuticals Stands Firm in Patent Dispute Over Key Epilepsy Treatment Read More